Group 1 - Beijing's GDP is projected to reach 5.2 trillion yuan by 2025, making it the second city in China to surpass this milestone after Shanghai, which is expected to reach 5 trillion yuan in 2024 and 5.67 trillion yuan in 2025 [1] - The economic growth in both cities is expected to be 5.4% year-on-year by 2025, which is higher than the national average [1] - In Beijing, the information, software, IT services, and financial sectors contribute over 80% to the economic growth, with these industries accounting for 51.8% of the city's GDP [1] Group 2 - In Shanghai, the service sector remains the primary growth engine, with significant contributions from the financial and IT industries, as well as strong growth in high-tech manufacturing sectors like integrated circuits and artificial intelligence [2] - Shanghai's retail sales are projected to grow by 4.6% year-on-year in 2025, driven by government initiatives and a surge in inbound tourism, with inbound consumption expected to reach $15 billion, a 35% increase [2] - Both cities are prioritizing innovation as a key growth driver, with Beijing planning to invest over 1.5 billion yuan in high-tech industries and set ambitious targets for computing power by 2027 [2][3] Group 3 - Shanghai's Pudong New Area has announced 50 key projects with a total investment exceeding 70 billion yuan, covering various sectors including finance, technology, and tourism [3] - The Shanghai government aims to establish the city as an "international consumption center" to boost inbound consumption and sustain growth over the next five years [3]

Financial Data and Key Metrics Changes - The company achieved an 11% revenue compound annual growth rate since 2020 and a 24% adjusted EPS compound annual growth rate [7] - Adjusted EBITDA margins expanded by 470 basis points, with free cash flow conversion at 106% [7] - For Q4, organic revenue grew 4%, with adjusted EPS growth of 10% [8] Business Line Data and Key Metrics Changes - Americas Commercial HVAC bookings increased by over 35% year-over-year, with revenue growth in low double digits [11] - Applied Solutions bookings surged more than 120%, achieving a record book-to-bill ratio of 200% [8] - EMEA HVAC bookings grew mid-teens, while Asia Pacific faced challenges with double-digit declines in bookings and revenue [12] Market Data and Key Metrics Changes - The backlog for commercial HVAC in the Americas rose approximately 25% and nearly 40% in EMEA compared to year-end 2024 [9] - The residential market showed mid-single-digit growth in bookings but mid-teens revenue decline due to inventory normalization [11] - The Americas transport refrigeration market bookings were down mid-single digits, outperforming a market decline of over 20% [12] Company Strategy and Development Direction - The company emphasizes a purpose-driven strategy focused on energy efficiency and sustainability, positioning itself to meet growing customer demand for smarter energy solutions [4] - Continued investment in innovation, services, and digital capabilities is expected to drive future growth [10] - The acquisition of Stellar Energy aims to enhance modular design capabilities and meet demand for prefabricated cooling systems [22] Management's Comments on Operating Environment and Future Outlook - Management anticipates a gradual recovery in residential and transport markets, with expectations for improved performance in the second half of 2026 [10][17] - The company is optimistic about its strong backlog and pipeline, projecting solid growth in 2026 [16] - Management remains cautious about the residential market, expecting it to be flat to down 5% in 2026 [19] Other Important Information - The company deployed approximately $3.2 billion in 2025 through its balanced capital allocation strategy, including dividends, M&A, and share repurchases [21] - The company expects to deploy between $2.8 billion and $3.3 billion in 2026 [22] Q&A Session Summary Question: Guidance on revenue for Americas Commercial HVAC - Management expects strong growth in the first quarter, around 7%-8%, increasing to low teens in the second half of the year due to strong bookings [27][28] Question: Confidence in residential inventory normalization and pricing - Management believes inventory is appropriately sized and has not seen pricing fade, with expectations for flat to down 5% in residential for the year [30][32] Question: Broadening of orders among end markets - Management reports broad-based growth across multiple verticals, not just data centers, indicating a healthy order pipeline [39][40] Question: Impact of customer lead times on applied orders - Management has not observed significant changes in lead times and remains competitive in that area [45] Question: Positioning in the data center market - Management emphasizes the importance of chillers in future data center designs and ongoing innovation in thermal management systems [58][66] Question: Insights on biopharma reshoring - Management is optimistic about large pharma projects related to reshoring but acknowledges that the Life Sciences vertical has not been positive recently [80][81]

1月29日晚间，归创通桥医疗科技股份有限公司(02190，以下简称"归创通桥"、"公司")发布2025年全年 业绩正面盈利预告。公司预期2025年全年净利润超过人民币2.4亿元，较去年同期大幅增长约139.4%； 营业收入超过人民币10.5亿元，同比增长约34.6%。 归创通桥表示，2025年公司业绩表现亮眼，主要受益于核心产品销售的强劲增长、海外业务的加速发展 以及运营效率的持续优化。报告期内，公司通桥麒麟血流导向装置、神经血管导丝、UltraFree药物洗脱 PTA球囊扩张导管、ZYLOX Swan静脉腔内射频闭合导管等产品销售收入均实现较快增长。国际业务方 面，公司海外市场销售收入同比增长超过100%，在德国、法国、意大利等重点国家市场的渗透率持续 提升。此外，在业务规模扩大的同时，公司持续推进运营效率提升，毛利率水平保持稳定，盈利能力进 一步增强。 2025年，归创通桥以"创新"与"国际化"为核心战略，持续推动业务布局与升级。报告期内，公司多款重 点创新产品相继获批上市。ZYLOX Mammoth大腔外周血栓抽吸导管、通桥飞龙颅内动脉瘤栓塞辅助支 架等产品实现商业化落地，并取得积极的市场表现。此外，公 ...

Group 1 - The APEC First Senior Officials' Meeting will be held in Guangzhou from February 1 to 10, 2026, focusing on the theme "Building a Community of the Asia-Pacific for Common Prosperity" and three priority areas: openness, innovation, and cooperation [1][2] - The meeting will feature over 70 activities with more than 1,000 representatives from APEC member economies, the secretariat, and business advisory councils expected to attend [1] - Guangzhou has attracted nearly $120 billion in foreign investment from APEC economies, accounting for 82.8% of the city's total foreign investment [2] Group 2 - Guangzhou has invested in 2,684 non-financial projects in 20 APEC economies, with a total investment amount of $24.72 billion, representing 81% of the city's total investment [2] - In 2025, Guangzhou's trade with APEC economies is projected to reach 689.58 billion yuan, a 2.2% increase, with exports at 443.61 billion yuan and imports at 245.97 billion yuan [2] - The city plans to enhance international payment environments and promote business cooperation by providing promotional materials about Guangzhou's business environment in hotels and hosting policy seminars [3] Group 3 - Guangzhou aims to create a vibrant atmosphere for foreign guests during the APEC meeting, integrating local cultural elements into events such as flower fairs and lantern festivals [3] - The city will mobilize over 2,000 enterprises to participate in 150 overseas exhibitions in APEC economies and organize over 30 exhibitions in countries like Vietnam and Indonesia [3] - Guangzhou will also conduct over 100 investment promotion activities in major cities of APEC economies and collaborate on building cooperative parks with APEC economies [3]

Core Insights - The recent visit of Finnish Prime Minister Orpo to China resulted in significant economic cooperation outcomes between China and Finland [3] - A memorandum of understanding was signed to enhance the work of the China-Finland Innovation Enterprises Cooperation Committee, indicating a commitment to collaborative innovation [3] - Over 50 companies from both countries engaged in discussions on cooperation in innovation, green technology, and digital sectors, leading to multiple commercial agreements in various industries [3] Economic Cooperation - The visit included the sixth meeting of the China-Finland Innovation Enterprises Cooperation Committee, highlighting the focus on innovation and collaboration [3] - Finnish companies expressed optimism about China's economic development and market potential, indicating a willingness to invest long-term in China [3] Future Initiatives - The Ministry of Commerce plans to work with Finland to implement the important consensus reached by the leaders of both countries [3] - There will be efforts to enhance policy communication in economic and trade matters and support Finnish companies in exporting quality products and services to China [3]

Core Viewpoint - China Galaxy Securities is optimistic about the pharmaceutical industry's investment opportunities in 2026, focusing on hard technology in medicine, innovation, and overseas expansion, while seeking alpha in niche segments [1] Group 1: Investment Trends - In Q4 2025, public fund holdings in pharmaceuticals decreased, indicating an overall low allocation level [1] - The market value of pharmaceutical theme funds decreased by 9.73% to 205.9 billion yuan, which is 66.54% higher than the average since 2019 [1] - The market value of the pharmaceutical biotechnology sector fell by 18.81% to 312.5 billion yuan, with a holding ratio of 8.12%, below the historical average by 3.89 percentage points [1] Group 2: Stock Performance - The top five pharmaceutical stocks held by public funds in Q4 2025 saw significant reductions in both the number of funds and total market value, with notable declines in stocks like Heng Rui Medicine and WuXi AppTec [2] - The concentration of holdings has shifted from innovative drugs to medical devices and services, indicating a change in market investment focus [2] Group 3: Industry Data Overview - The pharmaceutical manufacturing industry's revenue has shown a slight decline, with a year-on-year decrease of 1.2% in Q4 2025 [3] - Medical service volumes remained stable, with a total of 1.86 billion outpatient visits in early 2025, reflecting a 0.1% year-on-year decrease [3] - The overall operation of the medical insurance fund has been stable, with total income of 2.632 trillion yuan and total expenditure of 2.110 trillion yuan from January to November 2025 [3] Group 4: Market Comparison - The pharmaceutical industry has underperformed compared to the CSI 300 index, with a rolling P/E ratio of 38.19 compared to 14.14 for the CSI 300, indicating a premium of 170.14% over the index [3] - The SW pharmaceutical biotechnology index increased by 1.44% from early 2024 to January 28, 2026, while the CSI 300 rose by 37.15%, showing a relative underperformance of 35.71% for the pharmaceutical sector [3]

人民日报记者 李心萍 1月28日，国务院新闻办举行新闻发布会，国务院国资委公布央企2025年成绩单—— 2025年，中央企业实现利润总额2.5万亿元，完成固定资产投资5.1万亿元，上交税费2.5万亿元。截 至2025年底，中央企业资产总额突破95万亿元。 "2025年中央企业研发投入1.1万亿元，新增22位两院院士、创历史最好水平，23个创新联合体新吸 纳超过100家创新主体参与攻关。"庞骁刚说。 高投入，带来高产出。从"天问二号"、首艘电磁弹射型航母到"天权""钢铁脊梁号"，中央企业重大 创新成果竞相涌现。2025年，央企牵头或参与全部22个国家重大科技专项，攻克领跑技术121项。 中央企业运行呈现哪些新变化？2026年有哪些发力点？国务院国资委有关负责同志进行了介绍。 增强规模实力 "十四五"时期央企科技人才数量增加近50% "中央企业加快推进高质量发展，实现质的有效提升和量的合理增长"，国务院国资委副主任庞骁刚 总结央企"十四五"时期的发展成效。 规模增大，"十四五"时期中央企业资产总额连续跨上70万亿元、80万亿元、90万亿元台阶，年均增 速达6.9%；实现增加值51.3万亿元，比"十三五"时期增长4 ...

郭嘉昆表示，会议期间将举办50多场活动，预计将有来自APEC各成员经济体、秘书处、工商咨询理事 会等约1000名代表与会。目前各项筹备工作进展顺利。会议举办地广州历史悠久，是中国对外开放的重 要窗口和粤港澳大湾区的核心城市。 "我们欢迎各位记者朋友积极关注并报道第一次高官会及相关会议，讲好APEC'中国年'的故事。"郭嘉 昆说。 新华社北京1月28日电（记者邵艺博 朱超）外交部发言人郭嘉昆28日在例行记者会上说，中国作为2026 年亚太经合组织（APEC）东道主，将于2月1日至10日在广州举办APEC第一次高官会及相关会议。这 是APEC"中国年"首场正式活动。 "APEC高官会是为领导人会议准备成果的主渠道，每年举办四到五次。"郭嘉昆说，本次会议将聚焦 2026年APEC会议主题"建设亚太共同体，促进共同繁荣"和三大优先领域"开放、创新、合作"，全面启 动各领域各机制合作，深入讨论具体合作，为11月领导人非正式会议积累成果。 ...

转自：贵州日报 （《亚太经合组织"中国年"首场正式活动 2月1日至10日在广州举办》由贵阳日报为您提供，转载请注 明来源，未经书面授权许可，不得转载或镜像。） "APEC高官会是为领导人会议准备成果的主渠道，每年举办四到五次。"郭嘉昆说，本次会议将聚焦 2026年APEC会议主题"建设亚太共同体，促进共同繁荣"和三大优先领域"开放、创新、合作"，全面启 动各领域各机制合作，深入讨论具体合作，为11月领导人非正式会议积累成果。 郭嘉昆表示，会议期间将举办50多场活动，预计将有来自APEC各成员经济体、秘书处、工商咨询理事 会等约1000名代表与会。目前各项筹备工作进展顺利。会议举办地广州历史悠久，是中国对外开放的重 要窗口和粤港澳大湾区的核心城市。 据新华社电 外交部发言人郭嘉昆28日在例行记者会上说，中国作为2026年亚太经合组织（APEC）东道 主，将于2月1日至10日在广州举办APEC第一次高官会及相关会议。这是APEC"中国年"首场正式活动。 ...

1月28日早盘，科创板权重股高开后震荡回调截至午间收盘，科创成长指数上涨0.1%，科创200指数下跌0.6%，科创50指数、科创100指数均下跌0.7%，科创 综指下跌0.8%。 该指数污 科创200ETF易方达 IFF = = 2 跟踪上证科创板200指数 该指数由科创板中市值偏小、流动 性较好的200只股票组成,聚焦小 市值"成长潜力"科创企业,电子、 医药生物、机械设备行业合计占比 近70%,其中电子行业占比较高 截至午间 该指数润 科创综指ETF易方达 低费率 跟踪上证科创板综合指数 性较好的100只股票组成,聚焦中 小科创企业,电子、电力设备、医 药生物、计算机行业合计占比超 75%,其中电子、电力设备行业占 比较高 截至午间 该指数: 每日经济新闻 该指数由科创板全市场证券组成, 全面覆盖大、中、小盘风格,聚焦 人工智能、半导体、新能源、创新 ...